NPFF Activators

Chemical activators of NPFF can instigate a cascade of intracellular events leading to its activation. Forskolin directly stimulates adenylate cyclase, thereby increasing cAMP levels within the cell. This surge in cAMP activates protein kinase A (PKA), which can phosphorylate various intracellular targets, potentially including proteins associated with NPFF signaling. Similarly, Isoproterenol engages beta-adrenergic receptors, resulting in elevated cAMP and subsequent PKA activation. PKA, once activated, stands to phosphorylate proteins that are connected to NPFF function. Ionomycin and A23187 both raise intracellular calcium concentrations, which can activate PKC. This kinase is instrumental in phosphorylating proteins, including those that could be involved in NPFF's activity.

Other chemicals such as PMA and Phosphatidylserine activate PKC, which is known for its role in the phosphorylation of proteins that can include NPFF's associated factors. Anisomycin, though typically known as a protein synthesis inhibitor, can also activate JNK, a kinase that may phosphorylate components in the NPFF pathway. IBMX contributes to the activation of NPFF by inhibiting phosphodiesterases, preventing cAMP degradation, which leads to sustained PKA activation and subsequent phosphorylation of proteins involved in NPFF signaling. Epidermal Growth Factor (EGF) activates its receptor to initiate a cascade of kinase activations, potentially culminating in NPFF activation. Bryostatin 1 binds to PKC, modulating its activity, which in turn can lead to the phosphorylation of proteins within NPFF's signaling pathways. Zaprinast's inhibition of phosphodiesterases, particularly PDE5, results in cAMP accumulation and PKA activation, which then phosphorylates proteins involved in NPFF signaling. Lastly, Aluminum fluoride acts as an activator of heterotrimeric G-proteins, leading to the activation of downstream signaling that includes second messengers, which also can result in the activation of NPFF.